Daratumumab for Pediatric Heart Transplant Rejection 08/08/26
Welcome to Cardiology Today â Recorded August 08, 2026. This episode summarizes 5 key cardiology studies on topics like heart failure and endomyocardial biopsy. Key takeaway: Daratumumab for Pediatric Heart Transplant Rejection.
Article Links:
Article 1: Endometriosis and long-term risk of venous thromboembolism: a Danish nationwide study. (European heart journal)
Article 2: Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies. (European heart journal)
Article 3: Daratumumab for Non-Acute Antibody-Mediated Rejection After Pediatric Heart Transplantation: Treatment Response in the Presence and Absence of Circulating HLA Donor-Specific Antibody. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation)
Article 4: Prognostic Significance of Myocardial Blood Flow Reserve and Stress Myocardial Blood Flow in the Assessment of Cardiac Allograft Vasculopathy in Heart Transplant Recipients. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation)
Article 5: Impact of empagliflozin on serum calcium and phosphate in heart failure. (Journal of cardiac failure)
Full episode page: https://podcast.explainheart.com/podcast/daratumumab-for-pediatric-heart-transplant-rejection-08-08-26/
đ Featured Articles
Article 1: Endometriosis and long-term risk of venous thromboembolism: a Danish nationwide study.
Journal: European heart journal
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42568051
Summary: Endometriosis affects approximately 10 percent of women of reproductive age, with evidence linking it to systemic inflammation. This inflammatory process creates a recognized potential for increased venous thromboembolism risk. A Danish nationwide, registry-based cohort study comprehensively included all women with endometriosis from 1977 to 2024. The study rigorously matched these individuals 1 to 4 with controls based on birth and index year, representing a substantial effort to understand the association of endometriosis with long-term venous thromboembolism.
Article 2: Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies.
Journal: European heart journal
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42568038
Summary: Heart failure management has seen significant therapeutic and interventional advances; however, real-world clinical practice remains poorly characterized. This investigation utilized two major Japanese heart failure registries: JROADHF from 2013, comprising 13238 patients, and JROADHF-NEXT from 2019 to 2021, comprising 4016 patients. Patient outcomes were rigorously compared between the cohorts using 1-to-1 propensity score matching. This extensive comparison provides a temporal evaluation of heart failure management and its impact on outcomes.
Article 3: Daratumumab for Non-Acute Antibody-Mediated Rejection After Pediatric Heart Transplantation: Treatment Response in the Presence and Absence of Circulating HLA Donor-Specific Antibody.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42567380
Summary: L. A. Donor-Specific Antibody. Late graft survival following pediatric heart transplantation is inadequate, primarily due to chronic rejection. Daratumumab has demonstrated promise for treating antibody-mediated rejection, though published experience in heart transplantation is limited. This study retrospectively analyzed heart transplantation recipients who received daratumumab at a dose of 16 milligrams per kilogram for four doses. Treatment was administered for antibody-mediated rejection identified by elevated donor-derived cell-free D. N. A., without graft dysfunction or hemodynamic compromise, and confirmed by endomyocardial biopsy.
Article 4: Prognostic Significance of Myocardial Blood Flow Reserve and Stress Myocardial Blood Flow in the Assessment of Cardiac Allograft Vasculopathy in Heart Transplant Recipients.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42567379
Summary: Cardiac allograft vasculopathy significantly limits longevity following heart transplantation. Non-invasive physiological assessment using cardiac positron emission tomography offers established prognostic significance for this condition. This investigation included all adult single-organ heart transplant recipients who underwent Nitrogen-13 ammonia positron emission tomography myocardial perfusion imaging between 2016 and 2019. The study performed a median follow-up to measure the prognostic contribution of stress myocardial blood flow and myocardial blood flow reserve to post-transplant outcomes.
Article 5: Impact of empagliflozin on serum calcium and phosphate in heart failure.
Journal: Journal of cardiac failure
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42567257
Summary: Alterations in serum calcium and phosphate balance are associated with poor outcomes in heart failure, with existing data primarily from small observational studies. The effect of sodium-glucose cotransporter two inhibitors on serum calcium and phosphate levels has not been thoroughly examined in large, randomized heart failure trials. This study utilized comprehensive data from the EMPEROR-Pooled trials. The analysis focused on evaluating the prognostic associations of serum calcium and phosphate in heart failure patients and the specific impact of sodium-glucose cotransporter two inhibitors on these levels.
đ Transcript
Today’s date is August 08, 2026. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Endometriosis and long-term risk of venous thromboembolism: a Danish nationwide study. Endometriosis affects approximately 10 percent of women of reproductive age, with evidence linking it to systemic inflammation. This inflammatory process creates a recognized potential for increased venous thromboembolism risk. A Danish nationwide, registry-based cohort study comprehensively included all women with endometriosis from 1977 to 2024. The study rigorously matched these individuals 1 to 4 with controls based on birth and index year, representing a substantial effort to understand the association of endometriosis with long-term venous thromboembolism.
Article number two. Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies. Heart failure management has seen significant therapeutic and interventional advances; however, real-world clinical practice remains poorly characterized. This investigation utilized two major Japanese heart failure registries: JROADHF from 2013, comprising 13238 patients, and JROADHF-NEXT from 2019 to 2021, comprising 4016 patients. Patient outcomes were rigorously compared between the cohorts using 1-to-1 propensity score matching. This extensive comparison provides a temporal evaluation of heart failure management and its impact on outcomes.
Article number three. Daratumumab for Non-Acute Antibody-Mediated Rejection After Pediatric Heart Transplantation: Treatment Response in the Presence and Absence of Circulating H. L. A. Donor-Specific Antibody. Late graft survival following pediatric heart transplantation is inadequate, primarily due to chronic rejection. Daratumumab has demonstrated promise for treating antibody-mediated rejection, though published experience in heart transplantation is limited. This study retrospectively analyzed heart transplantation recipients who received daratumumab at a dose of 16 milligrams per kilogram for four doses. Treatment was administered for antibody-mediated rejection identified by elevated donor-derived cell-free D. N. A., without graft dysfunction or hemodynamic compromise, and confirmed by endomyocardial biopsy.
Article number four. Prognostic Significance of Myocardial Blood Flow Reserve and Stress Myocardial Blood Flow in the Assessment of Cardiac Allograft Vasculopathy in Heart Transplant Recipients. Cardiac allograft vasculopathy significantly limits longevity following heart transplantation. Non-invasive physiological assessment using cardiac positron emission tomography offers established prognostic significance for this condition. This investigation included all adult single-organ heart transplant recipients who underwent Nitrogen-13 ammonia positron emission tomography myocardial perfusion imaging between 2016 and 2019. The study performed a median follow-up to measure the prognostic contribution of stress myocardial blood flow and myocardial blood flow reserve to post-transplant outcomes.
Article number five. Impact of empagliflozin on serum calcium and phosphate in heart failure. Alterations in serum calcium and phosphate balance are associated with poor outcomes in heart failure, with existing data primarily from small observational studies. The effect of sodium-glucose cotransporter two inhibitors on serum calcium and phosphate levels has not been thoroughly examined in large, randomized heart failure trials. This study utilized comprehensive data from the EMPEROR-Pooled trials. The analysis focused on evaluating the prognostic associations of serum calcium and phosphate in heart failure patients and the specific impact of sodium-glucose cotransporter two inhibitors on these levels.
Thank you for listening. Don’t forget to subscribe.
đ Keywords
heart failure, endomyocardial biopsy, cohort study, sodium-glucose cotransporter two inhibitors, daratumumab, stress myocardial blood flow, empagliflozin, pediatric heart transplantation, clinical practice, antibody-mediated rejection, endometriosis, venous thromboembolism, positron emission tomography, serum calcium, women’s health, myocardial blood flow reserve, serum phosphate, systemic inflammation, patient outcomes, heart transplantation, donor-derived cell-free D. N. A., cardiac allograft vasculopathy, registries, temporal comparison.
âšī¸ About
Concise summaries of cardiovascular research for professionals.
Subscribe âĸ Share âĸ Follow